M R21 (Repaglinide 0.5 mg)
Pill imprint M R21 has been identified as Repaglinide 0.5 mg.
Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
More about repaglinide
- Other brands: Prandin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.